The ETFBKMT Knockout Raji Polyclonal Cells product is a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Raji B lymphocyte line, featuring targeted disruption of the ETFBKMT gene. This heterogeneous knockout pool enables functional studies of ETFBKMT without clonal selection biases, providing a robust loss-of-function model to investigate the gene’s role in mitochondrial electron transfer regulation. The polyclonal format preserves genetic diversity, reflecting population-level responses to gene disruption.
The host Raji cell line is an immortalized human B lymphocyte isolated from an EBV-positive Burkitt lymphoma. Widely employed in immunological and cancer research, Raji cells exhibit a lymphoblast-like morphology and rapid proliferation, making them suitable for high-throughput assays. Their EBV-positive background recapitulates aspects of B-cell malignancies, offering a clinically relevant context for studying metabolic adaptations in lymphoma.
ETFBKMT encodes a lysine methyltransferase that catalyzes the methylation of lysine residues on the electron transfer flavoprotein beta subunit (ETF??). This post-translational modification modulates ETF activity, which shuttles electrons from acyl-CoA dehydrogenases to ETF dehydrogenase (ETFDH) in the mitochondrial respiratory chain. ETFBKMT interacts directly with ETF?? and indirectly with ETFDH, functioning within the ETFBKMT?CETF?¨CETFDH axis. The methylation event is thought to be regulated by cellular energy status, linking metabolic demand to electron flux. Representative pathway constituents include ETF??, ETF??, ETFDH, and various acyl-CoA dehydrogenases, placing ETFBKMT at a critical node coupling fatty acid oxidation to oxidative phosphorylation.
In the Raji B lymphocyte context, disruption of ETFBKMT potentially alters mitochondrial electron transfer efficiency and fatty acid oxidation, processes vital for cancer cell energy homeostasis. Burkitt lymphoma cells often rely on metabolic reprogramming to sustain proliferation and survive stress, making ETFBKMT a relevant model for studying how protein methylation impacts these adaptations. Loss of ETFBKMT-mediated ETF?? methylation may impair electron shuttling, leading to metabolic vulnerabilities that could be explored for therapeutic targeting.
This knockout model supports diverse research applications, including the investigation of mitochondrial electron transfer regulation, epigenetic mechanisms in metabolism, and the role of protein methylation in cancer cell metabolism. Researchers can employ Western blotting to assess ETF?? methylation changes, Seahorse mitochondrial stress tests to measure bioenergetic profiles, RT-qPCR for knockout validation, and flow cytometry to monitor cell viability and proliferation. For additional product information, please contact Ascent Research.
